Monthly Intravitreal Anti-VEGF Injections Do Not Appear To Influence Fellow Eye CNV Development

Tuesday, June 15, 2010

Ocular Surgery News

Monthly anti-VEGF therapy does not appear to reduce the rate of new choroidal neovascular lesion development in the untreated fellow eye.

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

AdGlare Leaderboard